About CytoNest
CytoNest is a company based in Athens (United States) founded in 2020 by Nataraja S Yadavalli and Sergiy Minko.. CytoNest offers products and services including CytoNest™ Zein 3D Fiber Scaffold, CytoNest™ PCL Overlaid Fiber 3D Scaffold, and CytoNest™ PCL Fused Fiber 3D Scaffold. CytoNest operates in a competitive market with competitors including Nuclera Nucleics, CELLINK, OxSyBio, Collplant and Dimension Inx, among others.
- Headquarter Athens, United States
- Founders Nataraja S Yadavalli, Sergiy Minko
-
Sectors
ConsumerHealthcare Technology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cytonest, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$175 K (USD), Grant
Jul 01, 2023
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CytoNest
CytoNest offers a comprehensive portfolio of products and services, including CytoNest™ Zein 3D Fiber Scaffold, CytoNest™ PCL Overlaid Fiber 3D Scaffold, and CytoNest™ PCL Fused Fiber 3D Scaffold. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Edible scaffold inserts for 6-well plates used in cell growth applications.
Overlaid fiber inserts for enhanced cell manufacturing and scalability.
Fused fiber inserts designed for customizable cell culture environments.
Funding Insights of CytoNest
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $174,998
-
First Round
First Round
(01 Jul 2023)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2023 | Amount | Grant - CytoNest | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CytoNest
CytoNest has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include United States Department of Agriculture. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Leadership is provided on agriculture, food, and rural development matters.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CytoNest
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CytoNest
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cytonest Comparisons
Competitors of CytoNest
CytoNest operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nuclera Nucleics, CELLINK, OxSyBio, Collplant and Dimension Inx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Desktop bioprinter for genes and proteins production is developed.
|
|
| domain | founded_year | HQ Location |
3D bioprinters and bioinks are developed for research applications.
|
|
| domain | founded_year | HQ Location |
Provider of 3D printing of tissue biomaterials for medical research and clinical applications
|
|
| domain | founded_year | HQ Location |
Plant-derived collagen is developed for tissue repair and 3D bioprinting.
|
|
| domain | founded_year | HQ Location |
3D biomaterials are provided for regenerative medicine applications.
|
|
| domain | founded_year | HQ Location |
Developer of integrated 3D printing and tissue-engineering platform
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about CytoNest
When was CytoNest founded?
CytoNest was founded in 2020 and raised its 1st funding round 3 years after it was founded.
Where is CytoNest located?
CytoNest is headquartered in Athens, United States.
Who is the current CEO of CytoNest?
Nataraja S Yadavalli is the current CEO of CytoNest. They have also founded this company.
What does CytoNest do?
CytoNest was founded in 2020 and is based in Athens, United States. 3D scaffolds are produced by the company for cell culture technology in sectors such as tissue engineering, cultured meat, cultured seafood, and regenerative medicine. Research applications are supported through these scaffolds, which facilitate advancements in biotechnology and related fields. Operations focus on manufacturing and distribution to meet demands in these areas.
Who are the top competitors of CytoNest?
CytoNest's top competitors include Nuclera Nucleics, Collplant and CELLINK.
What products or services does CytoNest offer?
CytoNest offers CytoNest™ Zein 3D Fiber Scaffold, CytoNest™ PCL Overlaid Fiber 3D Scaffold, and CytoNest™ PCL Fused Fiber 3D Scaffold.
Who are CytoNest's investors?
CytoNest has 1 investor. Key investors include United States Department of Agriculture.